Results
17
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
17 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
VBSN | CHF 136.00 | -0.7% | 21.4% | CHF 323.9m | n/a | PE21.4x | n/a | 2.4% | Healthcare | ||
DCN | CHF 750.00 | 0% | 7.1% | CHF 120.6m | n/a | PE12.5x | n/a | 0% | Tech | ||
CFT | CHF 150.00 | 2.4% | 28.2% | CHF 1.2b | n/a | PE12.4x | n/a | 4.0% | Diversified Financials | ||
ELMN | CHF 1,020.00 | -1.0% | 1.0% | CHF 233.1m | n/a | PE26x | n/a | 0.2% | Tech | ||
LMN | CHF 19.84 | 3.0% | -10.6% | CHF 212.0m | CHF 25.98 | PE23.4x | E30.0% | 2.9% | Consumer Services | ||
TIBN | CHF 40.60 | 1.0% | -6.0% | CHF 136.4m | n/a | PE13.2x | S10.7% | 0% | Consumer Services | ||
NEAG | CHF 38.40 | -0.3% | -10.9% | CHF 1.3b | CHF 65.00 | PE11.6x | E3.3% | 2.2% | Utilities | ||
APGN | CHF 197.50 | -0.3% | 7.9% | CHF 591.5m | CHF 235.50 | PE22.1x | S1.7% | 5.6% | Media | ||
SANN | CHF 9.00 | 2.9% | 11.1% | CHF 105.5m | CHF 34.50 | PE1.9x | E32.5% | n/a | Pharmaceuticals & Biotech | ||
JFN | CHF 204.50 | -0.2% | 31.8% | CHF 1.1b | CHF 260.00 | PE14.4x | E2.6% | 3.2% | Transportation | ||
BRKN | CHF 90.50 | 1.3% | 0.2% | CHF 960.6m | CHF 101.00 | PE18.5x | E6.0% | 4.9% | Capital Goods | ||
VZUG | CHF 58.20 | -3.3% | -12.2% | CHF 374.1m | CHF 74.00 | PE23.3x | E38.7% | n/a | Consumer Durables | ||
OFN | CHF 76.00 | 0.8% | 4.7% | CHF 149.0m | CHF 91.20 | PE16.9x | E17.9% | 5.1% | Commercial Services | ||
REHN | CHF 53.00 | -2.6% | 0.8% | CHF 1.4b | CHF 62.73 | PE6.4x | E-23.4% | 2.7% | Utilities | ||
VETN | CHF 30.90 | 0.7% | -31.9% | CHF 612.6m | CHF 42.00 | PE9.7x | E7.6% | 3.2% | Materials | ||
PMN | CHF 438.00 | -1.1% | 16.8% | CHF 418.3m | CHF 460.56 | PE10.4x | E8.5% | 6.5% | Capital Goods | ||
ASCN | CHF 5.82 | 5.4% | -46.9% | CHF 209.0m | CHF 9.67 | PE13.8x | E16.4% | 5.2% | Healthcare |